The World’s Most Influential Healthcare Event
Solving Healthcare’s Biggest Challenges
November 30-December 1, 2016 | New York City
The stakes are literally life and death. A barrage of problems: Alzheimer’s, opioids, and new infectious diseases, are set to hit the healthcare system at a time when we’re failing to insure that everyone gets effective care. If we can’t afford today’s breakthroughs, what will that mean for tomorrow?

The summit is invite-only and limited to 200 CEO leaders.


*Subject to Change


Wednesday, November 30, 2016




Inventing Breakthroughs -- And Paying For Them

New drugs for cancer and heart failure have come from Novartis’ labs. New ideas on how to pay for them have come from the C-suite. CEO Joseph Jimenez is here to answer Forbes’ questions -- and yours.

  • Joseph Jimenez | Chief Executive Officer , Novartis
  • Moderator: Matthew Herper | Senior Editor, Pharma & Healthcare , Forbes Media

Creating Value in Healthcare

Everyone is saying the word “value.” What does it mean? The billionaire behind the Walgreen’s Boots Alliance gives us his unique -- and international -- perspective.

  • Stefano Pessina | Executive Vice Chairman & Chief Executive Officer , Walgreens Boots Alliance
  • Moderator: Moira Forbes | Publisher, ForbesWoman; Executive Vice President , Forbes Media

Creating New Solutions For Our Collective Future

  • Matthias F. Platsch | President, Services , Siemens Healthineers

Cocktail Reception Sponsored by Siemens Healthineers


Cocktail Reception Concludes, Salon Dinners (By Special Invitation Only)


Thursday, December 1, 2016




Opening Remarks

  • Matthew Herper | Senior Editor, Pharma & Healthcare , Forbes Media

Spotlight: Where is Pricing Going?

  • Peter Gilmore | Principal, KPMG Strategy – Healthcare & Life Sciences , KPMG LLP

Pharma All-Stars: Coming To A Consensus On Drug Prices

Why are drug prices high? Some blame the complicated web of rebates between the manufacturer and the patient. A discussion aimed at finding solutions.

  • Steve Miller, M.D. | Senior Vice President & Chief Medical Officer , Express Scripts
  • Brent Saunders | Chief Executive Officer , Allergan
  • Moderator: Matthew Herper | Senior Editor, Pharma & Healthcare , Forbes Media

Spotlight: The Dawn of Bioelectronic Medicine

A new breakthrough: treatments that use the body’s electric fields to influence health.

  • Kevin Tracey, M.D. | President & Chief Executive Officer, Feinstein Institute for Medical Research; Executive Vice President , Northwell Health

A New Way Of Thinking About Healthcare

Insurers and doctors used to think one patient at a time. Now they have to see the big picture to keep whole populations healthy. That changes everything.

  • August Calhoun, PhD | Senior Vice President, North America Services , Siemens Healthineers
  • Deborah DiSanzo | General Manager , IBM Watson Health
  • Michael Dowling | President & Chief Executive Officer , Northwell Health
  • Jessica Mega M.D., MPH | Chief Medical Officer , Verily
  • Moderator: Harlan Krumholz | Contributor; Harold H. Hines, Jr. Professor of Medicine , Forbes Media; Yale University Healthcare

Pharma All-Stars: Fighting Cancer

New advances  in immune and genetic therapy are changing the way cancer is treated. Their costs are raising questions. Can we afford this age of breakthroughs?

  • Mark Alles | Chief Executive Officer , Celgene
  • Giovanni Caforio, MD | Chief Executive Officer , Bristol-Myers Squibb
  • Kenneth Frazier | Chairman & Chief Executive Officer , Merck & Co.
  • Robert Nelsen | Co-Founder & Managing Director , ARCH Venture Partners
  • Moderator: Matthew Herper | Senior Editor, Pharma & Healthcare , Forbes Media

Morning Break


The Future Of Health Insurance

Everything is about to change again. What will the health insurance business look like as it faces a new political world, and new technologies? The nuts and bolts of a patient revolution.

  • Bruce Broussard | President & Chief Executive Officer , Humana Inc.
  • Diane P. Holder | Executive Vice President, UPMC; President, UPMC Insurance Services Division; President & Chief Executive Officer , UPMC Health Plan
  • Daniel Loepp | President & Chief Executive Officer , Blue Cross Blue Shield of Michigan
  • Mario Schlosser | Co-Founder & Chief Executive Officer , Oscar
  • Moderator: Avik Roy | Opinion Editor , Forbes Media

Moving Mylan Forward

Mylan’s price increases for EpiPen created a public firestorm. After becoming a household name for all the wrong reasons, what will the company do next?

  • Heather Bresch | Chief Executive Officer , Mylan
  • Moderator: Matthew Herper | Senior Editor, Pharma & Healthcare , Forbes Media

From Satellites To Pharmaceuticals

Martine Rothblatt helped create satellite radio – then her daughter became sick, and she changed the drug business.

  • Martine Rothblatt | Founder & Chief Executive Officer , United Therapeutics Corporation
  • Moderator: Dean Kamen | Founder, FIRST; President , DEKA Research & Development

Spotlight: Sequencing Newborns

  • Robert C. Green, MD, MPH | Director, Genomes2People Research Program , Brigham & Women's Hospital & Harvard Medical School
  • Lauren Stetson | Newborn Genomic Sequencing Participant

How to Live to Be 100

  • Richard Rothman, MD, PhD | Founder , Rothman Institute



Spotlight: Is Virtual Reality Medicine’s New Reality?

  • Danny Belch | Vice President, Business Development , STRIVR Labs
  • Hunter Hillenmeyer | Head of Strategic Partnerships , STRIVR Labs

A Textbook For Disruption

Health stocks are booming again, but can health care valuations stay as high as they’ve been? A new billionaire, the architect of the year’s biggest biotech deal, Mayo’s expert in start-up inspiration and a healthcare technology pioneer give us their thoughts.

  • Osman Kibar, PhD | Founder & Chief Executive Officer , Samumed
  • David Hung, M.D. | Co-Founder, President & Chief Executive Officer , Medivation
  • Gianrico Farrugia, M.D. | Vice President & Chief Executive Officer , Mayo Clinic Florida
  • Owen Tripp | Co-Founder & Chief Executive Officer , Grand Rounds
  • Moderator: Josh Wolfe | Co-Founder & Managing Partner , Lux Capital

On-Demand Healthcare Economy

It used to be that patients would come to you and then wait. Not anymore. New ideas about how doctors and caregivers can go to patients.

  • Ann Lamont | Managing Partner , Oak HC/FT
  • John Sculley | Chairman, RxAdvance & Vice Chairman , MDLive
  • Jeroen Tas | Chief Executive Officer, Healthcare Informatics Solutions & Services , Philips
  • Moderator: Moira Forbes | Publisher, ForbesWoman; Executive Vice President , Forbes Media

Afternoon Break


Healing The Brain

Susan Schneider Williams watched her husband, the legendary actor Robin Williams, battle “a terrorist in his brain”: the disease called Lewy Body Dementia. Now she wants to see more money poured into brain disease research. Forbes is introducing her to two entrepreneurs who have raised more than $700 million to test brain drugs, including one for Lewy body.

  • Vivek Ramaswamy | Founder & Chief Executive Officer , Roivant Sciences & Axovant Sciences
  • Ryan J. Watts, PhD | President & Chief Executive Officer , Denali Therapeutics
  • Moderator: Susan Schneider Williams | Artist , Susan Schneider Fine Art
  • Moderator: Michael Noer | Executive Editor , Forbes Magazine

Pharma All-Stars: Restoring Pharma’s Reputation

The drug industry is front and center in a national dialogue. How do we make sure  patients around the world can get the medicines they need? Can we balance costs and the need for innovation? Pharma leaders answer Forbes’ questions – and yours.

  • John F. Milligan, Ph.D. | Chief Executive Officer , Gilead Sciences
  • Ian Read | Chairman of the Board & Chief Executive Officer , Pfizer
  • David Ricks | Incoming President & Chief Executive Officer, Eli Lilly and Company; President, , Lilly Bio-Medicines
  • Jim Robinson | President , Astellas Americas
  • Leonard Schleifer | Chief Executive Officer , Regeneron Pharmaceuticals
  • Moderator: Matthew Herper | Senior Editor, Pharma & Healthcare , Forbes Media

Closing Remarks

  • Matthew Herper | Senior Editor, Pharma & Healthcare , Forbes Media

Closing Reception


Reception Concludes

2015 Forbes Healthcare Summit


Jazz at Lincoln Center

Jazz At Lincoln Center, 3 Columbus Circle, New York, NY, 10019

Directions »


Interested in attending?

Forbes Healthcare Summit is by invitation only. Attendance is limited in order to maintain an intimate dialogue among all participants.



Presented By


Supporting Sponsors

Innovation Showcase Sponsors

Video Highlights

Pharma All-Stars: Restoring Pharma's Reputation


Moving Mylan Forward


Pharma All-Stars: Fighting Cancer


Healing The Brain


On-Demand Healthcare Economy


A New Way Of Thinking About Healthcare


The Future Of Health Insurance


A Textbook For Disruption


Spotlight: The Dawn of Bioelectronic Medicine


Spotlight: Where is Pricing Going?


EnergyFocus Jeremy Heilman


Northwell KevinTracey


BlueCross Dan Leopp


Siemens Matthias Franz Platsch


Philips Jeron Tas


City Of Hope Don Diamond


Bayer Chris Loder


Northwell Tom Thornton


BlueCross Paul Gerrard


Philips Nick Padula


Astellas Launches Global Campaign in Collaboration with CNN as Part of Global Corporate Brand Activity



  • For Sponsorship Inquiries:
  • Melody Khodaverdian
  • Director, Conference Partnerships
  • 917.794.5859 | mkhodaverdian@forbes.com
  • For Invitation and Attendee Inquiries:
  • Rich Guh
  • Audience Development Associate
  • 212.620.1861 | healthcare@forbes.com
  • For Event Management & Logistics:
  • Jessica Charles
  • Event Coordinator
  • 212-620-1872 | healthcare@forbes.com
  • For Press Inquiries and Press Passes:
  • Laura Daunis
  • Senior Manager of Corporate Communications
  • 1 (212) 367-4874 | Ldaunis@forbes.com
  • For Press Inquiries:
  • Christina Vega
  • Manager, Editorial Publicity at Forbes
  • 212.206.5155 | cvega@forbes.com

Click here for information on how to nominate a potential speaker.

General Questions?Please fill out the form below and someone will get in touch with you.